Skip to main content
Top
Published in: BMC Medicine 1/2019

Open Access 01-12-2019 | Care | Research article

The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care

Authors: Alexander Pate, Richard Emsley, Darren M. Ashcroft, Benjamin Brown, Tjeerd van Staa

Published in: BMC Medicine | Issue 1/2019

Login to get access

Abstract

Background

Risk prediction models are commonly used in practice to inform decisions on patients’ treatment. Uncertainty around risk scores beyond the confidence interval is rarely explored. We conducted an uncertainty analysis of the QRISK prediction tool to evaluate the robustness of individual risk predictions with varying modelling decisions.

Methods

We derived a cohort of patients eligible for cardiovascular risk prediction from the Clinical Practice Research Datalink (CPRD) with linked hospitalisation and mortality records (N = 3,855,660). Risk prediction models were developed using the methods reported for QRISK2 and 3, before adjusting for additional risk factors, a secular trend, geographical variation in risk and the method for imputing missing data when generating a risk score (model A–model F). Ten-year risk scores were compared across the different models alongside model performance metrics.

Results

We found substantial variation in risk on the individual level across the models. The 95 percentile range of risks in model F for patients with risks between 9 and 10% according to model A was 4.4–16.3% and 4.6–15.8% for females and males respectively. Despite this, the models were difficult to distinguish using common performance metrics (Harrell’s C ranged from 0.86 to 0.87). The largest contributing factor to variation in risk was adjusting for a secular trend (HR per calendar year, 0.96 [0.95–0.96] and 0.96 [0.96–0.96]). When extrapolating to the UK population, we found that 3.8 million patients may be reclassified as eligible for statin prescription depending on the model used. A key limitation of this study was that we could not assess the variation in risk that may be caused by risk factors missing from the database (such as diet or physical activity).

Conclusions

Risk prediction models that use routinely collected data provide estimates strongly dependent on modelling decisions. Despite this large variability in patient risk, the models appear to perform similarly according to standard performance metrics. Decision-making should be supplemented with clinical judgement and evidence of additional risk factors. The largest source of variability, a secular trend in CVD incidence, can be accounted for and should be explored in more detail.
Appendix
Available only for authorised users
Literature
1.
go back to reference Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016;353(1 Pt 2):i2416. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27184143%5Cn; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4868251 Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016;353(1 Pt 2):i2416. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​27184143%5Cn; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4868251
3.
go back to reference Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336(7659):1475–82.CrossRefPubMedPubMedCentral Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336(7659):1475–82.CrossRefPubMedPubMedCentral
6.
go back to reference Deanfield J, Sattar N, Simpson I, Wood D, Bradbury K, Fox K, et al. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100:ii1–ii67. Deanfield J, Sattar N, Simpson I, Wood D, Bradbury K, Fox K, et al. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100:ii1–ii67.
9.
go back to reference Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009.
10.
go back to reference Harrell FEH, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.CrossRefPubMed Harrell FEH, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.CrossRefPubMed
13.
go back to reference Van Staa TP, Gulliford M, Ng ESW, Goldacre B, Smeeth L. Prediction of cardiovascular risk using framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk? PLoS One. 2014;9(10):e106455.CrossRefPubMedPubMedCentral Van Staa TP, Gulliford M, Ng ESW, Goldacre B, Smeeth L. Prediction of cardiovascular risk using framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk? PLoS One. 2014;9(10):e106455.CrossRefPubMedPubMedCentral
14.
go back to reference Hofer E. The uncertainty analysis of model results. Springer International Publishing; 2018. Hofer E. The uncertainty analysis of model results. Springer International Publishing; 2018.
17.
go back to reference Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–36.CrossRefPubMedPubMedCentral Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–36.CrossRefPubMedPubMedCentral
20.
go back to reference Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ. 2010;340(July):c2442.CrossRefPubMedPubMedCentral Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ. 2010;340(July):c2442.CrossRefPubMedPubMedCentral
21.
go back to reference Allgulander C. Anxiety as a risk factor in cardiovascular disease. Curr Opin Psychiatry. 2016;29(1):13–7.CrossRefPubMed Allgulander C. Anxiety as a risk factor in cardiovascular disease. Curr Opin Psychiatry. 2016;29(1):13–7.CrossRefPubMed
24.
go back to reference Peckham S, Falconer J, Gillam S, Hann A, Kendall S, Nanchahal K, Ritchie B, Rogers R, Wallace A. The organisation and delivery of prevention and health promotion in general practice and primary care: a scoping study: Chapter 7. Health Serv Deliv Res. 2015;3:29.CrossRef Peckham S, Falconer J, Gillam S, Hann A, Kendall S, Nanchahal K, Ritchie B, Rogers R, Wallace A. The organisation and delivery of prevention and health promotion in general practice and primary care: a scoping study: Chapter 7. Health Serv Deliv Res. 2015;3:29.CrossRef
25.
go back to reference Van Buuren S, Groothuis-Oudshoon K. MICE: Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1–67. Van Buuren S, Groothuis-Oudshoon K. MICE: Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1–67.
27.
go back to reference Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57. Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57.
28.
go back to reference Choodari-Oskooei B, Royston P, Parmar MKB. A simulation study of predictive ability measures in a survival model I: explained variation measures. Stat Med. 2012;31(23):2627–43.CrossRefPubMed Choodari-Oskooei B, Royston P, Parmar MKB. A simulation study of predictive ability measures in a survival model I: explained variation measures. Stat Med. 2012;31(23):2627–43.CrossRefPubMed
29.
go back to reference Rahman MS, Ambler G, Choodari-Oskooei B, Omar RZ. Review and evaluation of performance measures for survival prediction models in external validation settings. BMC Medical Res Methodol. 2017;17(1):1–15.CrossRef Rahman MS, Ambler G, Choodari-Oskooei B, Omar RZ. Review and evaluation of performance measures for survival prediction models in external validation settings. BMC Medical Res Methodol. 2017;17(1):1–15.CrossRef
30.
go back to reference Austin PC, Pencinca MJ, Steyerberg EW. Predictive accuracy of novel risk factors and markers: a simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model. Stat Methods Med Res. 2017;26(3):1053–77.CrossRefPubMed Austin PC, Pencinca MJ, Steyerberg EW. Predictive accuracy of novel risk factors and markers: a simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model. Stat Methods Med Res. 2017;26(3):1053–77.CrossRefPubMed
31.
go back to reference Uno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30(10):1105–17.PubMedPubMedCentral Uno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30(10):1105–17.PubMedPubMedCentral
33.
go back to reference Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med. 2004;23:723–48.CrossRefPubMed Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med. 2004;23:723–48.CrossRefPubMed
35.
go back to reference O’Quigley J, Xu R, Stare J. Explained randomness in proportional hazards models. Stat Med. 2005;24(3):479–89.CrossRefPubMed O’Quigley J, Xu R, Stare J. Explained randomness in proportional hazards models. Stat Med. 2005;24(3):479–89.CrossRefPubMed
36.
go back to reference Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med Stat Med. 1999;18:2529–45.CrossRefPubMed Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med Stat Med. 1999;18:2529–45.CrossRefPubMed
37.
go back to reference Gerds TA, Schumacher M. Consistent estimation of the expected brier score in general survival models with right-censored event times. Biom J. 2006;48(6):1029–40.CrossRefPubMed Gerds TA, Schumacher M. Consistent estimation of the expected brier score in general survival models with right-censored event times. Biom J. 2006;48(6):1029–40.CrossRefPubMed
38.
go back to reference Kent JT, O’Quigley J. Measures of dependence for censored survival data. Biometrika. 1988;75(3):525–34.CrossRef Kent JT, O’Quigley J. Measures of dependence for censored survival data. Biometrika. 1988;75(3):525–34.CrossRef
39.
go back to reference Royston P. Explained variation for survival models. Stata J. 2006;6:83–96.CrossRef Royston P. Explained variation for survival models. Stata J. 2006;6:83–96.CrossRef
40.
go back to reference Choodari-Oskooei B, Royston P, Parmar MKB. A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy. Stat Med. 2012;31(23):2644–59.CrossRefPubMed Choodari-Oskooei B, Royston P, Parmar MKB. A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy. Stat Med. 2012;31(23):2644–59.CrossRefPubMed
41.
go back to reference ClinRisk. QRISK2 online calculator, Information, What is the difference between an “estimated” QRISK®2 CVD score and an “actual” QRISK®2 CVD score? [Internet]. [cited 2018 Dec 7]. Available from: https://qrisk.org/2017/index.php. ClinRisk. QRISK2 online calculator, Information, What is the difference between an “estimated” QRISK®2 CVD score and an “actual” QRISK®2 CVD score? [Internet]. [cited 2018 Dec 7]. Available from: https://​qrisk.​org/​2017/​index.​php.
46.
go back to reference Pajouheshnia R, Damen JAAG, Groenwold RHH, Moons KGM, Peelen LM. Treatment use in prognostic model research: a systematic review of cardiovascular prognostic studies. Diagnostic Progn Res BioMed Central. 2017;1(1):15. Pajouheshnia R, Damen JAAG, Groenwold RHH, Moons KGM, Peelen LM. Treatment use in prognostic model research: a systematic review of cardiovascular prognostic studies. Diagnostic Progn Res BioMed Central. 2017;1(1):15.
48.
go back to reference Jenkins DA, Sperrin M, Martin GP, Peek N. Dynamic models to predict health outcomes: current status and methodological challenges. Diagnostic Progn Res. 2018;2(1):1–9.CrossRef Jenkins DA, Sperrin M, Martin GP, Peek N. Dynamic models to predict health outcomes: current status and methodological challenges. Diagnostic Progn Res. 2018;2(1):1–9.CrossRef
50.
go back to reference Hooper L, Summerbell CD, Higgins JPT, Thompson RL, Capps NE, Smith GD, et al. Dietary fat intake and prevention of cardiovascular disease: systematic review. Br Med J. 2001;322:757–63.CrossRef Hooper L, Summerbell CD, Higgins JPT, Thompson RL, Capps NE, Smith GD, et al. Dietary fat intake and prevention of cardiovascular disease: systematic review. Br Med J. 2001;322:757–63.CrossRef
51.
go back to reference Brown WJ, Pavey T, Bauman AE. Comparing population attributable risks for heart disease across the adult lifespan in women. Br J Sports Med. 2015;49(16):1069–76.CrossRefPubMed Brown WJ, Pavey T, Bauman AE. Comparing population attributable risks for heart disease across the adult lifespan in women. Br J Sports Med. 2015;49(16):1069–76.CrossRefPubMed
52.
go back to reference Weng SF, Kai J, Guha IN, Qureshi N. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Hear. 2015;2(1):e000272.CrossRefPubMedPubMedCentral Weng SF, Kai J, Guha IN, Qureshi N. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Hear. 2015;2(1):e000272.CrossRefPubMedPubMedCentral
53.
go back to reference Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43.CrossRefPubMed Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43.CrossRefPubMed
54.
go back to reference Berezin AE. Biomarkers for cardiovascular risk in patients with diabetes. Heart. 2016;102(24):1939–41.CrossRefPubMed Berezin AE. Biomarkers for cardiovascular risk in patients with diabetes. Heart. 2016;102(24):1939–41.CrossRefPubMed
55.
go back to reference Dhingra R, Vasan R. Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. Trends Cardiovasc Med. 2017;27(2):123–33.CrossRefPubMed Dhingra R, Vasan R. Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. Trends Cardiovasc Med. 2017;27(2):123–33.CrossRefPubMed
56.
go back to reference Harrel F. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001. Harrel F. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
57.
go back to reference Liew SM, Blacklock C, Hislop J, Glasziou P, Mant D. Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them. Br J Gen Pract. 2013;63(611):401–7.CrossRef Liew SM, Blacklock C, Hislop J, Glasziou P, Mant D. Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them. Br J Gen Pract. 2013;63(611):401–7.CrossRef
60.
go back to reference Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. Bmj. 2010;342(7788):93. Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. Bmj. 2010;342(7788):93.
61.
go back to reference Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211.CrossRef Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211.CrossRef
63.
go back to reference O’Quigley J, Stare J. Proportional hazards models with frailties and random effects. Stat Med. 2002;21(21):3219–33.CrossRefPubMed O’Quigley J, Stare J. Proportional hazards models with frailties and random effects. Stat Med. 2002;21(21):3219–33.CrossRefPubMed
Metadata
Title
The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care
Authors
Alexander Pate
Richard Emsley
Darren M. Ashcroft
Benjamin Brown
Tjeerd van Staa
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Care
Published in
BMC Medicine / Issue 1/2019
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-019-1368-8

Other articles of this Issue 1/2019

BMC Medicine 1/2019 Go to the issue